+----------------------------+ | Media Manufacturer | | - Quality System Checks | | - Lot Performance Data | +--------------+-------------+ | v +----------------------------+ | Regional Distributor | | - Cold Chain Integrity | | - Safe Storage / Handling | +--------------+-------------+ | v +----------------------------+ | Clinical End-User | | - Visual Verification | | - Non-Exempt Testing | +----------------------------+ 1. Manufacturer Requirements
Navigating CLSI M22-A3: Standards for Quality Control of Microbiological Culture Media
Label each type as either Exempt or Non-Exempt based on M22-A3 criteria. clsi m22a3 pdf link
Nevertheless, many laboratories may choose to follow CLIA quality assurance regulations directly. For laboratories that elect to use an IQCP for media listed as exempt in M22-A3, the CAP explicitly allows laboratories to "accept quality control performed by the media manufacturer in lieu of performing its own end user quality control".
However, CLSI M22-A3 is directly relevant to anaerobic bacteriology in an important way. High-quality, prereduced anaerobic media are critical for successful anaerobic culture. Poor media quality is a leading cause of false‑negative results. By ensuring the quality of these specialized media, M22-A3 supports the reliable performance of downstream susceptibility testing methods, including the CLSI‑standardized agar dilution and broth microdilution methods for anaerobes. Therefore, while distinct, M22-A3 and AST documents work in concert to ensure laboratory quality. For laboratories that elect to use an IQCP
The standard provides essential guidance for all commercial media listed in its Table 2, regardless of packaging, plate, or tube design. It is designed to assist laboratories in determining which commercially prepared media require routine quality control testing by the end user.
Microbiological culture media are the foundation of diagnostic bacteriology. If the medium fails to support the growth of a pathogen or fails to inhibit commensal flora as intended, the clinical result could be a false negative, leading to misdiagnosis. The M22-A3 standard balances the need for rigorous safety with the practicalities of laboratory workflow. 2. The Concept of "Exempt" Media Poor media quality is a leading cause of
In microbiology laboratories, diagnostic precision depends heavily on the consistency and performance of culture media. Substandard media can suppress pathogenic growth, generate false negatives, or lead to inaccurate antimicrobial susceptibility results.
Highly selective or complex media that have higher failure rates or critical clinical impact (e.g., Chocolate agar for fastidious organisms, Campylobacter media). Laboratories must perform full in-house QC testing on every lot of non-exempt media before clinical use. Benefits of Implementing CLSI M22-A3